Filing Details
- Accession Number:
- 0000899243-19-006263
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-05 18:56:40
- Reporting Period:
- 2019-03-01
- Accepted Time:
- 2019-03-05 18:56:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1217234 | Caredx Inc. | CDNA | Services-Medical Laboratories (8071) | 943316839 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1702824 | Brian Michael Bell | C/O Caredx, Inc. 3260 Bayshore Boulevard Brisbane CA 94005 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-03-01 | 25,000 | $0.00 | 102,060 | No | 4 | A | Direct | |
Common Stock | Disposition | 2019-03-01 | 11,770 | $31.64 | 90,290 | No | 4 | F | Direct | |
Common Stock | Disposition | 2019-03-01 | 13,000 | $31.36 | 77,290 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- The reported securities were represented by restricted performance stock units that were granted on October 20, 2017, 100% of which vested on March 1, 2019 upon the achievement of the requisite performance criteria.
- These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.15 to $31.495, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.